Introduction
============

Atopic dermatitis (AD) in infants frequently progresses to asthma and allergic rhinitis in childhood. This progression is known as atopic march. In fact, more than 50% of patients with moderate-to-severe AD develop asthma, while 8% of the people without AD suffer from asthma.[@b1-jaa-10-181],[@b2-jaa-10-181] The development of various atopic diseases shares complex and heterogeneous, but common pathogenesis including increment in IgE production, enhanced Th2 allergic reactions, and impaired barrier function.[@b2-jaa-10-181] Barrier dysfunction and subsequent early life exposure to allergen are considered as triggers for atopic march.[@b2-jaa-10-181],[@b3-jaa-10-181] However, we still lack a detailed picture of the progression of atopic diseases from AD to asthma.

One of the major problems with investigating the link among atopic diseases is probably the lack of a proper animal model. Some research groups have developed animal models induced by repeated allergic sensitization of ovalbumin through impaired skin barriers, followed by intranasal exposure, for the purpose of studying the progression of atopic diseases.[@b4-jaa-10-181],[@b5-jaa-10-181]

Recently, we developed a rat model of AD with chronically relapsing dermatitis and scratching behaviors induced by neonatal capsaicin treatment. In the previous study, we showed how neonatal capsaicin treatment interfered with epithelial barrier function, which possibly resulted in the development of chronic pruritic cutaneous lesions.[@b6-jaa-10-181] Thus, we could infer a link between AD and asthma from epithelial barrier dysfunction. In fact, Long et al[@b7-jaa-10-181] reported that chronic expsoure of SO~2~ simutaneously with neonatal capsaicin treatment altered airway responsiveness in adult rats.

Here, we proposed that the AD model produced by neonatal capsaicin treatment also showed asthmatic changes such as Th2 allergic inflammation in the airway, airway remodeling, and airway hyperresponsiveness (AHR).

Materials and methods
=====================

Animals
-------

All experiments were approved by the Institutional Animal Care and Use Committee in College of Medicine, Korea University (KOREA-2016-0024), and animals were maintained in the facility compliant with the Korean Ministry of Food and Drug Safety Standard Guideline based on Guide for the Care and Use of Laboratory Animals (8th edition). Pregnant Sprague Dawley rats (Samtako, South Korea) were acquired 2 or 3 days before parturition. Newborns were weaned at postnatal week 3, and only the males were used. All animals were reared in a room maintained at a 12-h light/dark cycle (light on at 7:00 AM) at 22--25°C and had ad libitum access to food and water.

Neonatal capsaicin treatment
----------------------------

As previously described,[@b6-jaa-10-181] neonatal rats were injected subcutaneously with capsaicin (capsaicin-treated group, 50 mg/kg; Sigma) or vehicle (control group, saline containing 10% Tween 80 and 10% ethanol) at a volume of 10 ml/g body weight within 24 h of birth.

Evaluation of pruritus
----------------------

Rats were placed in separate plastic chambers (20×30×20 cm) containing a mirror for prevention of a blinded view. The scratching behaviors were recorded for an hour using a digital video camera (HDR-CX380; Sony, Tokyo, Japan) every week for 6 weeks. The video files were played back, and the number of scratches was assessed by blind experimenters unaware of the allocation of treatments. A bout of consecutive scratching strokes was regarded as one scratch ([Video S1](http://dvpr.es/2nhjyjQ)).

Evaluation of cutaneous lesions
-------------------------------

Cutaneous lesions were carefully appraised using the score system[@b8-jaa-10-181] with modifications. The skin lesions in three different regions (the ears, face, and back) were assessed every week for 6 weeks to evaluate the severity and extent of lesions. The unit size for the measurement of cutaneous lesions was 0.25 cm^2^, and the dermatitis score was determined by the unit size multiplied by the severity index, which is defined in [Table 1](#t1-jaa-10-181){ref-type="table"}.

Sampling of the tissues
-----------------------

After behavioral testing for 6 weeks, rats were sacrificed using CO~2~ gas. After that, lesional skin in the middle of the back of the neck (or the nearest lesional part) was acquired from the capsaicin-treated rats. The non-lesional skin in the same region was obtained from the control rats. Blood was collected with cardiac puncture using a 1 ml syringe, and then both the lobes of the lung were acquired for histological analysis and quantitative real-time polymerase chain reaction (RT-PCR). All samples were stored at −70°C and used within 2 weeks of collection.

Enzyme-linked immunosorbent assay (ELISA)
-----------------------------------------

The IgE levels of serum and bronchoalveolar lavage (BAL) fluid were determined using a rat IgE ELISA Kit (CUSA-BIO), according to the manufacturer's protocol.

Quantitative RT-PCR
-------------------

The tissues were homogenized, and RNA was obtained using TRIzol Reagent (Thermo Fisher Scientific). Synthesis of cDNA was performed using M-MLV reverse transcriptase (Thermo Fisher Scientific). Quantitative PCR (qPCR) was performed in duplicate using the GoTaq qPCR Master Mix (Promega) on a Roche LightCycler 96 (Roche). Primers are described in [Table 2](#t2-jaa-10-181){ref-type="table"}.

Bronchoalveolar lavage
----------------------

After the rats in both the groups were sacrificed, the airway was cannulated with a 16-gauge needle and lavaged once with 5 ml of phosphate-buffered saline (PBS). The fluid collected from airway lavage was defined as BAL fluid, and was centrifuged, and the supernatant was used for ELISA. The cell pellet was treated with red blood cell lysis buffer (eBioscience) and washed in PBS. The resultant cells were fixed with methyl alcohol and stained with hematoxylin and eosin. The number of total cells was counted in duplicate with a hemocytometer. More than 250 cells were used to determine the differential cell count.

Lung histology
--------------

The lungs were removed, washed in PBS, and then fixed in 10% neutral buffered formalin solution (Sigma). After fixation, they were embedded in paraffin, and lung sections were cut into 4-μm samples. Slides were stained either with hematoxylin and eosin or Masson's trichrome (Trichrome III Blue Staining Kit; Ventana Medical Systems), and more than three different sections of each lung were evaluated under light microscopy. Only the airways whose lumen diameter was from 50 to 200 μm were included in the evaluation.

For evaluating airway remodeling, we measured the amount of mucus plug and the extent of smooth muscle hypertrophy. First, to assess the amount of mucus plug in the airways, we adopted a scoring system, and the size of the area was measured using Image J (NIH). The sum of the scores from each airway of all the slides was taken as the mucus plug score in arbitrary units, which is shown in [Table 3](#t3-jaa-10-181){ref-type="table"}. Next, to calculate smooth muscle hypertrophy, we considered (A/C)\*(B/C) as smooth muscle thickness ratio ([Figure 1](#f1-jaa-10-181){ref-type="fig"}). The largest width of smooth muscle in the section was considered as the smooth muscle thickness (A). The major axis of the airway lumen (C) and the minor axis of the airway lumen (B) were used. We divided A by C to correct the bias from the size of the lumen, and (B/C) was multiplied to compensate the bias from the tilt angle of the section. The sum of the smooth muscle thickness ratio from each airway was divided by the number of airways examined, and stated in arbitrary units. If B/C was smaller than 2/3, the ratio was dropped from the calculation to exclude angled sections.

Measurement of airway responsiveness
------------------------------------

AHR to methacholine (acetyl-b-methylcholine chloride; Sigma) was evaluated in rats of 6 weeks of age using a computer-controlled small-animal ventilator (flexiVent; SCIREQ). Rats were anesthetized with sodium pentobarbital (50 mg/kg) via intraperitoneal injection. The rats were intubated with a 16-gauge metallic needle and connected to flexiVent machine. Lung mechanics (airway resistance and compliance) were measured in every rat after nebulization of PBS for the baseline using an ultrasonic nebulizer (Aeroneb; SCIREQ). After measurement of the baseline, a methacholine challenge test was conducted. Rats were challenged with methacholine at the following doses: 6.25, 12.5, 25, and 50 mg/ml. Then, the rats were ventilated in a constant-flow inflation mode with a tidal volume of 10 ml/kg, an inspiratory--expiratory ratio of 2:3, a respiratory rate of 120 breaths/min, and maximum pressure of 30 cm H~2~O. Positive end-expiratory pressure was maintained by submerging the expiratory limb in a water trap.

Statistical analysis
--------------------

Results were expressed as mean ± standard error of the mean. Data were analyzed using the Student's *t*-test or the Mann--Whitney rank-sum test, depending on results from the normality test.

Results
=======

AD-like symptoms and amplification of Th2-dominant immune response
------------------------------------------------------------------

To confirm whether neonatal capsaicin treatment caused AD-like symptoms in rats, we examined cutaneous lesions and scratching behaviors for 6 weeks. Dermatitis first appeared at 3 weeks of age and became aggravated over the following weeks in the capsaicin-treated rats unlike the control rats ([Figure 2A](#f2-jaa-10-181){ref-type="fig"}). At 3 weeks of age, the number of scratches also started to increase significantly in the capsaicin-treated rats compared to the control rats and persisted until 6 weeks of age ([Figure 2B](#f2-jaa-10-181){ref-type="fig"}). Serum IgE level was remarkably higher in the capsaicin-treated rats than in the control rats at 6 weeks of age ([Figure 2C](#f2-jaa-10-181){ref-type="fig"}). To determine whether the skin inflammation was attributed to enhanced Th2 allergic response, we investigated cytokine production in the skin. At 6 weeks of age, mRNA expression of Th2 cytokines such as IL-4, IL-5, and IL-13 was markedly elevated in the skin of the capsaicin-treated rats compared to the control rats ([Figure 2D](#f2-jaa-10-181){ref-type="fig"}), but mRNA expression of Th1 cytokines such as TNF-α and IFN-γ showed no significant alteration ([Figure 2E](#f2-jaa-10-181){ref-type="fig"}).

Eosinophil infiltration in the airway and increment of mRNA expression of Th2 cytokines in the lung
---------------------------------------------------------------------------------------------------

To investigate asthmatic progression in the airway and the lungs, we examined the total cell count, differential cell count, and IgE levels in BAL fluid. Although no significant difference in the number of leukocytes was observed between the capsaicin-treated rats and the control rats ([Figure 3A and B](#f3-jaa-10-181){ref-type="fig"}), the percentage of eosinophils in the total cell count was significantly higher in the capsaicin-treated rats compared to control rats ([Figure 3A and C](#f3-jaa-10-181){ref-type="fig"}). The IgE level in BAL fluid was also remarkably higher in the capsaicin-treated rats than in control rats ([Figure 3D](#f3-jaa-10-181){ref-type="fig"}). To investigate whether Th2 allergic inflammation was as enhanced in the lung as in the skin, the mRNA expression of Th2 and Th1 cytokines was quantified. Similar to the skin, mRNA expression of Th2 cytokines such as IL-4, IL-5, and IL-13 was higher in the lung of the capsaicin-treated rats compared to control rats ([Figure 3E](#f3-jaa-10-181){ref-type="fig"}), even though no remarkable difference was recorded for the mRNA expression of Th1 cytokines such as TNF-α and IFN-γ ([Figure 3F](#f3-jaa-10-181){ref-type="fig"}).

Airway remodeling and AHR
-------------------------

To determine concurrent airway remodeling, we analyzed the histological features of the airway. Morphological analysis revealed extensive mucus plug and smooth muscle hypertrophy ([Figure 4A](#f4-jaa-10-181){ref-type="fig"}). The amount of mucus plug expressed was markedly higher in the capsaicin-treated rats than in the control rats ([Figure 4B](#f4-jaa-10-181){ref-type="fig"}). The ratio of smooth muscle thickness, indicative of smooth muscle hypertrophy, was significantly higher in capsaicin-treated rats compared to control rats ([Figure 4C](#f4-jaa-10-181){ref-type="fig"}). Furthermore, collagen deposition around airways was also increased in capsaicin-treated rats ([Figure S1A](#SD1-jaa-10-181){ref-type="supplementary-material"}) compared to control rats ([Figure S1B](#SD1-jaa-10-181){ref-type="supplementary-material"}). Airway resistance in response to methacholine was remarkably higher in the capsaicin-treated rats than in the control rats in a dose-dependent fashion, with the exception of rats exposed to 12.5 mg/ml methacholine ([Figure 4D](#f4-jaa-10-181){ref-type="fig"}). Lung compliance in response to methacholine was also much lower in the capsaicin-treated rats than in the control rats at doses of 6.25 and 25 mg/ml, but not with 12.5 and 50 mg/ml ([Figure 4E](#f4-jaa-10-181){ref-type="fig"}). Furthermore, even at the doses showing a lack of statistical significance, alteration of airway resistance and compliance demonstrated the same tendency.

Discussion
==========

We developed a rat model of AD induced by neonatal capsaicin treatment.[@b6-jaa-10-181] In the present study, the model showed not only AD-like symptoms but also asthmatic changes such as elevated levels of IgE, Th2 allergic inflammation, airway remodeling, and AHR in adolescent period. Taken together, this model could be useful for studying the progression of atopic diseases.

As previously described,[@b6-jaa-10-181] the capsaicin-treated rats developed chronically relapsing dermatitis and pruritus starting at 3 weeks of age. The expression pattern of inflammatory cytokines in [Figure 2](#f2-jaa-10-181){ref-type="fig"} supports the idea that allergic reactions of Th2, but not Th1, played a pivotal role in the clinical manifestation of AD-like symptoms in the capsaicin-treated rats. Elevated serum IgE level in the capsaicin-treated rats was also consistent with the feature of atopic diseases as AD and asthma are almost invariably accompanied by elevated levels of IgE.[@b9-jaa-10-181]

In accordance with the results in [Figure 3A--C](#f3-jaa-10-181){ref-type="fig"}, human studies provided evidence that the number of eosinophils increased in patients with asthma, while the total cell count of asthma patients did not differ from controls.[@b10-jaa-10-181],[@b11-jaa-10-181] In addition, IgE production and Th2-associated immune responses are features of asthmatics.[@b12-jaa-10-181],[@b13-jaa-10-181] Crimi et al[@b14-jaa-10-181] reported that total IgE/K^+^ ratio in bronchial lavage was higher in asthmatics than in controls, which was consistent with the results in [Figure 3D](#f3-jaa-10-181){ref-type="fig"}. Inflammatory Th2 cytokines such as IL-4 and IL-13 released from eosinophils contributed to asthmatic symptoms.[@b15-jaa-10-181] Furthermore, Th2 cells promoted allergic reactions in asthmatics by amplifying production of cytokines including IL-4, IL-5, and IL-13, which resulted in IgE production, along with AHR and tissue remodeling.[@b16-jaa-10-181],[@b17-jaa-10-181] Thus, the elevated mRNA expression of Th2 cytokines shown in [Figure 3E](#f3-jaa-10-181){ref-type="fig"} possibly contributed to the airway remodeling and asthmatic symptoms in the capsaicin-treated rats.

The complex interplay between aberrant immune response and chronic inflammation leads to the progression of airway remodeling in asthmatics.[@b18-jaa-10-181],[@b19-jaa-10-181] Airway smooth muscle hypertrophy has been accepted as a distinctive feature of asthmatic remodeling, though there are controversial reports regarding the degree of hypertrophy.[@b20-jaa-10-181],[@b21-jaa-10-181] Furthermore, the airway of asthma patients is characterized by hyperproduction of mucus as well as persistent inflammation and eosinophil infiltration.[@b22-jaa-10-181]--[@b24-jaa-10-181] Histological analysis of the airway of the capsaicin-treated rats revealed asthmatic features such as smooth muscle hypertrophy and increased mucus plug in agreement with previous reports. AHR is defined as the aggravation of airway obstruction in response to bronchoconstrictors and is a diagnostic symptom of asthma. Progressive increment of airway resistance at increasing doses of methacholine is regarded as AHR in rodents. Moreover, when significant airflow obstruction occurs, compliance decreases substantially during tidal breath in asthma.[@b25-jaa-10-181] Increased airway resistance and decreased compliance, shown in [Figure 4D and E](#f4-jaa-10-181){ref-type="fig"}, run parallel to the characteristic airway responsiveness of asthma.

AD and asthma share a common pathogenesis and immunologic features including elevated IgE, overproduction of Th2 cytokines, and barrier dysfunction.[@b2-jaa-10-181] Several studies provided evidence that sensitization through a disrupted skin barrier enhanced the Th2 cytokine expression[@b26-jaa-10-181] and subsequent migration of Th2 cells through the circulatory system promoted an allergic response in the airways.[@b27-jaa-10-181] We previously demonstrated the impairment of skin barrier function in our model,[@b6-jaa-10-181] which was plausibly attributed to inflammatory reactions due to neuronal cell death by neonatal capsaicin treatment.[@b28-jaa-10-181] Overexpression of inflammatory mediators including IL-13 contributed to the induction of atopic diseases such as AD in rodents even without deliberate allergen exposure.[@b29-jaa-10-181],[@b30-jaa-10-181] Thus, such barrier dysfunction and inflammatory response possibly facilitated spontaneous early-life allergen sensitization, which contributed to the development of asthma as well as AD.[@b31-jaa-10-181] However, the role of inflammation or neuronal cell death in the pathogenesis of allergic diseases through a damaged barrier in our model needs to be confirmed.

In summary, our results suggest that our model induced by neonatal capsaicin treatment could be suitable for the study of atopic march from the perspective of clinical manifestation and intrinsic pathogenesis.

Supplementary materials
=======================

###### 

Increased collagen deposition in the airways.

**Note:** Representative slides revealed relative abundance of collagen deposition in the airways from the capsaicin-treated rats (**A**) compared to control rats (**B**) (scale bar=50 μm).
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![Schematic representation of the airway lumen and surrounding smooth muscle.](jaa-10-181Fig1){#f1-jaa-10-181}

![Atopic dermatitis-like skin inflammation, pruritus, and amplification of Th2 inflammatory reactions.\
**Notes:** Chronological features of cutaneous inflammatory lesion (**A**) and scratching behaviors (**B**). Elevated serum IgE level was observed in the capsaicin-treated rats (**C**). In the skin of the capsaicin-treated rats, mRNA expression of Th2 cytokines such as IL-4, IL-5, and IL-13 was increased compared to control rats (**D**), but mRNA expression of Th1 cytokines such as TNF-α and IFN-γ was not significantly changed (**E**). ns=not significant; \**p*\<0.05; \*\**p*\<0.005.](jaa-10-181Fig2){#f2-jaa-10-181}

![Eosinophil infiltration and elevated expression of Th2 cytokines.\
**Notes:** Representative illustration of eosinophil predominance in the BAL fluid of capsaicin-treated rats (top, **A**) compared to control rats (bottom, **A**). Arrows indicates eosinophil in BAL fluid (**A**). No significant difference in total number of leukocytes in BAL fluid (**B**). In the capsaicin-treated rats compared to control rats, differential cell count in BAL fluid demonstrated increment of eosinophil (**C**) and IgE level in BAL fluid markedly increased (**D**). In the lung of the capsaicin-treated rats, mRNA expression of Th2 cytokines such as IL-4, IL-5, and IL-13 was increased (**E**), but mRNA expression of Th1 cytokines such as TNF-α and IFN-γ was not altered (**F**). \**p*\<0.05; \*\*\**p*\<0.001 (scale bar =10 μm).\
**Abbreviations:** BAL, bronchoalveolar lavage; ns, non significant.](jaa-10-181Fig3){#f3-jaa-10-181}

![Airway remodeling and airway hyperresponsiveness.\
**Notes:** Photographs showed hematoxylin and eosin staining of airways from the capsaicin-treated rats (top, **A**) and control rats (bottom, **A**). Arrow indicates mucus plug in the airway and double-headed arrow indicates smooth muscle thickness of the airway (**A**). Mucus plug markedly increased in the capsaicin-treated rats (**B**). Analysis of the ratio of smooth muscle thickness demonstrated smooth muscle hypertrophy in the capsaicin-treated rats (**C**). After exposure to increasing doses of methacholine, in the capsaicin-treated rats, the airway resistance increased at doses of 6.25, 25, and 50 mg/ml (**D**). Inhalation of methacholine at doses of 6.25 and 25 mg/ml markedly reduced lung compliance in the capsaicin-treated rats (**E**). \**p*\<0.05 (scale bar=100 μm).](jaa-10-181Fig4){#f4-jaa-10-181}

###### 

Severity index for the dermatitis score

  Region   Score                Description
  -------- -------------------- -------------
  Face     0                    Normal
  1        Wispy fur            
  2        Alopecia or flare    
  3        Bleeding or scab     
  Ears     0                    Normal
  1        Flare                
  2        Bleeding or scab     
  3        Loss of the tissue   
  Back     0                    Normal
  1        Wispy fur            
  2        Alopecia or flare    
  3        Bleeding or scab     

###### 

Primers used in quantitative real-time polymerase chain reaction

  Gene    Primer (forward)       Primer (reverse)
  ------- ---------------------- ----------------------
  GAPDH   ACTTTGGCATCGTGGAAGGG   ACATTGGGGGTAGGAACACG
  IL-4    ACCTTGCTGTCACCCTGTTC   ACCTTGCTGTCACCCTGTTC
  IL-5    GAGGGGGCACTGTGGAAATA   ACTCATCACGCCAAGGAACT
  IL-13   CCTGGAATCCCTGACCAACA   GCCATAGCGGAAAAGTTGCT
  IFN-γ   AGTTCGAGGTGAACAACCCA   CAGAATCAGCACCGACTCCT
  TNF-α   GAAAGTCAGCCTCCTCTCCG   CTCCAAAGTAGACCTGCCCG

###### 

Scoring system for measuring the amount of mucus plug in the airway

  The size of mucus plug area/the size of airway lumen area (%)   Score
  --------------------------------------------------------------- -------
  0--5                                                            0
  5--10                                                           1
  10--25                                                          2
  25--50                                                          3
  50--100                                                         4
